直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • 联邦巡回法院知识产权博客
    • INCONTESTABLE® Blog
    • Prosecution First博客
  • Events & Webinars
  • 知识产权讯息
  • 播客
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Panel Discussion

The 3rd China Pharma, Biotech & Chemical IP Forum and Innovation Exhibition

May 25-27, 2012

Taizhou, China

China Medical City

Finnegan is a silver sponsor of The 3rd China Pharma, Biotech & Chemical IP Forum and Innovation Exhibition conference. Finnegan partner Barbara Rudolph will participate in the panel discussion on "Biological Drug Development." Partner Jennifer Swan will participate in the panel discussion on "Patent Enforcement" and partner Ningling Wang will chair the panel discussion on "Patent Procurement and Enforcement in China." This event will be held in Taizhou, China.

Related Professionals

王 宁 玲
合伙人
Shanghai
+86 21 6194 2005
Email

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Seminar

Future IP UK

October 21, 2026

London

Conference

Singapore IP Week 2026

August 26-27, 2026

Seminar

IAM and WTR Live: Australasia IP Forum 2026

August 11, 2026

Melbourne

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Federal Circuit IP Blog

Federal Circuit Affirms Indefiniteness of the Term “About”

June 10, 2026

Seminar

High-Stakes, High-Tech IP Disputes in the United States

June 9, 2026

Beijing

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP